
(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays - 2
'Heated Rivalry's Ilya Rozanov is now a queer icon in Russia - 3
Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book - 4
David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home. - 5
12 times rockets and spacecraft crashed and burned in 2025
Fire Allegedly Triggered by Wedding Cake Sparkler Causes Venue to Go Up in Flames, Leaving Groom with Second-Degree Burns
6 U.S. States for Climbing
Discovering a sense of harmony: Individual Accounts of Reflection and Care
Indian Health Service is digging out of decades-old construction backlog for medical buildings
How to watch 2026 Golden Globe winners like 'One Battle After Another,' 'Adolescence' and 'The Pitt'
I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
25 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine
See tonight’s solar storm unfold across the world
Astronomers may have spotted the 1st known 'superkilonova' double star explosion













